These findings demonstrated that, under TGF-β1 stimulation, the knockdown of these genes led to a significant decrease in the expression of fibrotic markers, highlighting the potential therapeutic relevance of targeting CALD1, CDH2, and POSTN for attenuating fibrotic processes in pulmonary fibrosis. The gene discussed is TGFB1; the disease is pulmonary fibrosis.